CGEN Compugen Limited: Multiplikator nilai perusahaan marang pendapatan

Logo perusahaan publik Compugen Ltd (CGEN)

The EV/Sales trajectory for Compugen Ltd. (CGEN) on GURU.Markets correlates with moderate capacity utilization of antibody synthesis laboratories, while 934.15 reflects the latest metric value. A high barrier to entry is ensured by the patent portfolio and strict FDA oversight. Compugen Ltd. (CGEN) is also developing a science and technology hub, combining AI-driven target discovery with biology to create unique methods for combating tumors.

Nilai perusahaan marang pendapatan: Compugen Limited (CGEN) kanggo 23.11.2025 - 19.11.2026

Compugen Limited - rincian analitis lan metrik utama (CGEN)

- rega saham lan konsensus proyeksi valuasi:
Analisis wiwitan perusahaan:Compugen Ltd CGEN
Sampel barang Compugen Ltd

The stable IP monetization strategy led by Anat Cohen-Dayag is reflected in the shift of the EV/Sales ratio for Compugen Ltd. (CGEN). This metric compares the total enterprise value of the business with annual revenue, excluding the impact of leverage. The calculation combines market capitalization and net debt, divided by revenue. Low values signal either undervaluation or a systemic crisis in the model. This tool allows for the identification of institutional accumulation phases of the asset.

Analisis pesaing Compugen Ltd.

IBRX (immunitybio.com) - Rasio nilai perusahaan marang pendapatan|Immunocore Corp (IMCR) - Rasio nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Janux Pharma (JANX)|Nilai perusahaan marang pendapatan RCUS|ZYME - Rasio nilai perusahaan marang dodolan|Nilai perusahaan marang pendapatan TNGX (Tango Pharma)|Koefisien nilai perusahaan marang pendapatan IOVA|Multiplikator EV/Sales IMTX (Immatics)|Nilai bisnis marang pendapatan XNCR|compasstherapeutics.com - Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Replimune Inc.|Lyell Immunopharma (LYEL) - Rasio nilai perusahaan marang pendapatan|Innate Pharma S.A. - Nilai bisnis marang pendapatan|PYXS (Pyxis) - Multiplikator EV/Sales|Multiplikator EV/Sales IO Biotech Inc|Rasio nilai perusahaan marang pendapatan Sutro Biopharma (STRO)|INKT: Nilai perusahaan marang volume dodolan|Werewolf Therapeutics, Inc. - Nilai perusahaan marang pendapatan|Immix (IMMX) - Multiplikator nilai perusahaan marang pendapatan|ALX Oncology Holdings Inc. - Multiplikator EV/Sales|CUE - Multiplikator EV/Sales|PDSB: Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Sonnet BioTherapeutics Holdings Inc. (SONN)|MAIA (MAIABiotech.com) - Multiplikator EV/Sales|Nilai perusahaan marang pendapatan Liminatus Pharma (LIMN)|Multiplikator EV/Sales LVTX|Koefisien nilai perusahaan marang pendapatan NXTC|Leap Therapeutics, Inc. - Nilai perusahaan marang pendapatan|INTS: Rasio nilai perusahaan marang pendapatan|Sensei Biotherapeutics Inc - Multiplikator EV/Sales|TOVX: Rasio nilai perusahaan marang pendapatan|gritstonebio.com (GRTS) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan KA|Rasio nilai perusahaan marang pendapatan NexImmune, Inc.|Rasio nilai perusahaan marang pendapatan TSBX (Turnstone Biologics)|Nilai perusahaan marang pendapatan VCNX (Vaccinex, Inc.)|Koefisien nilai perusahaan marang pendapatan HARP